Publications Database

Naruse H. et al. (1987)

Therapeutic effect of tetrahydrobiopterin in infantile autism.

Proceedings of the Japan Academy

63(6), pp.231-233

Read Abstract (New Window)

Naviaux R. K. et al. (2017)

Low-dose suramin in autism spectrum disorder: a small, phase I-II, randomized clinical trial.

Annals of Clinical and Translational Neurology,Neurology

4(7),

Read Abstract (New Window) Read Full (New Window)

Ney P. , Neal T. (1988)

Double blind cross-over trial with fenfluramine.

Canadian Journal of Psychiatry

pp. 574

Niederhofer H. , Staffen W. , Mair A. (2002)

Galantamine may be effective in treating autistic disorder.

British Medical Journal

325(7377), pp. 1422

Read Full (New Window)

Niederhofer H. , Staffen W. , Mair A. (2003)

Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.

Human Psychopharmacology

18(5), pp. 389-393

Read Abstract (New Window)

Nikoo M. , Radnia H. , Farokhnia M. (2015)

N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.

Clinical Neuropharmacology

January, 38(1), pp. 11-17.

Read Abstract (New Window)

Owen R. et al. (2009)

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

Pediatrics

124(6), pp. 1533-1540.

Read Abstract (New Window) Read Full (New Window)

Pandina G. J. et al. (2006)

Risperidone improves behavioral symptoms in children with autism. in a randomized, double-blind, placebo-controlled trial.

Journal of Autism and Developmental Disorders

37(2), pp.367-373.

Read Abstract (New Window)

Parker K. J. et al. (2017)

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.

PNAS

114(30), pp. 8119–8124.

Read Abstract (New Window)

Pusponegoro H. D. et al. (2015)

Gluten and casein supplementation does not increase symptoms in children with autism spectrum disorder.

Acta Paediatrica

November, 104(11), e500-505.

Read Abstract (New Window)

Quintana D. S. et al. (2017)

Dose-dependent social-cognitive effects of intranasal oxytocin.

Translational Psychiatry

May, 7(5), e. 1136.

Read Abstract (New Window)

Quintana H. et al. (1995)

Use of methylphenidate in the treatment of children with autistic disorder.

Journal of Autism and Developmental Disorders

25(3), pp. 283-294

Read Abstract (New Window)

Ratliff-Schaub K. et al. (2005)

Randomized controlled trial of transdermal secretin on behavior of children with autism.

Autism

9(3),

Read Abstract (New Window)

Remington G. et al. (2001)

Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study.

Journal of Clinical Psychopharmacology

21(4), pp. 440-444

Read Abstract (New Window)

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network (2005)

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Archives of General Psychiatry

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network 62(11), pp. 1266-1274

Read Abstract (New Window) Read Full (New Window)

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network (2005)

Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.

American Journal of Psychiatry

162(7), pp. 1361-1369

Read Abstract (New Window) Read Full (New Window)

Rezaei V. et al. (2010)

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(7), pp. 1269-1272.

Read Abstract (New Window)

Rimland B. , Callaway E. , Dreyfus P. (1978)

The effect of high doses of Vitamin B6 on autistic children: a double-blind crossover study

American Journal of Psychiatry

135(4), pp. 472-475

Read Abstract (New Window)

Ritvo E. R. et al. (1984)

Study of fenfluramine in outpatients with the syndrome of autism.

Journal of Pediatrics

105 pp. 823-828

Read Abstract (New Window)

Robb A. S. et al. (2011)

Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies.

Primary Care Companion to CNS Disorders

13(1), pii: PCC.10m01008

Read Abstract (New Window) Read Full (New Window)